Inhibition of Presenilins Attenuates Proliferation and Invasion in Bladder Cancer Cells Through Multiple Pathways

Jun-Wei Gai,Wasilijiang Wahafu,Ya-Ching Hsieh,Miao Liu,Liang Zhang,Sheng-Wen Li,Bei Zhang,Qun He,Hui Guo,Jie Jin

DOI: https://doi.org/10.1016/j.urolonc.2013.02.014

2014-01-01

Abstract:Objective: Presenilin (PS)/gamma-secretase is a key protease that initiates various biological processes. We investigated the effect of PS/gamma-secretase on the expression and inhibition of umthelial cell carcinoma of bladder (UCB) as a potential alternative therapeutic target for UCB. Materials and methods: PS-1 and PS-2 were identified in normal and malignant human bladder transitional cells by immunohistochemistry. We blocked PSs using a PS/gamma-secretase inhibitor N-(N-[3,5-difluorophenacetyl]-L-alanyl)-S-phenylglycine-t-butylester (DAPT), and the proliferative and invasive potential of UCB cells SW780, BIU-87, 5637, and T24, and human normal urothelial cell line SV-HUC-1 were analyzed using Western blot, cell viability test, flow cytometry, and transwell assay. All experiments were repeated at least 3 times. Results: Human bladder samples of UCB, SW780, BIU-87, 5637, and T24 cells expressed higher PS-1 compared with normal ones. Cell vitality test demonstrated that DAPT attenuated UCB cell proliferation more than SV-HUC-1. Flow cytometry and transwell assay showed that T24 cells were arrested at G1/S checkpoint and its invasive ability was impaired. Western blot assay markedly showed that protein levels of CD44-intracellular domain, insulinlike growth factor-IR beta, extracellular regulated protein kinase 1/2, cyclin D1, proliferating cell nuclear antigen, and matrix metalloproteinase-9 were downregulated by DAPT, whereas vascular endothelial growth factor receptor-2 and vascular endothelial growth factor-165 were upregulated. Conclusions: Our study revealed that PS-1 might be implicated in the proliferation and invasion of UCB. and that it may serve as a potential therapeutic target for UCB, but further studies are warranted to verify the effects of inhibition of PS/gamma-secretase on angiogenesis. (C) 2014 Elsevier Inc. All rights reserved.